TAE Life Sciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1756 Cloverfield Blvd, Santa Monica, Cal...Phone Number
(949) 830-2117Website
www.taelifesciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About TAE Life Sciences
TAE Life Sciences is pioneering advancements in cancer treatment through its innovative Boron Neutron Capture Therapy (BNCT) technology. The company focuses on providing effective treatment options for patients with challenging malignancies, utilizing a biologically targeted radiotherapy approach that minimizes damage to healthy tissues. Their proprietary Alphabeam Neutron System enhances the delivery of this therapy, ensuring precision in targeting cancer cells. TAE Life Sciences aims to transform cancer care by developing therapies that can be administered in just one to two treatment sessions.Explore more
TAE Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is TAE Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
TAE Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on TAE Life Sciences recently announced quarterly report
Funding: Get notified immidiatlly once TAE Life Sciences has new funding data
Product Launch: Get notified when TAE Life Sciences launches new products
Website visits: Recent activity has been detected on your website
Click to see if TAE Life Sciences had a recent Job posting/layoffs
Check if TAE Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if TAE Life Sciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at TAE Life Sciences
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to TAE Life Sciences
Compare insights from companies similar to TAE Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
TAE Life Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
TAE Life Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about TAE Life Sciences.
TAE Life Sciences financials insights
Gather financial insights about TAE Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$40M
2020
Series B
$30M
TAE Life Sciences Tech Stack
A closer look at the technologies used by TAE Life Sciences
Most Recent Scoops
Open Position
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Promotion
Executive Move
Funding
TAE Life Sciences News & Media
TAE Life Sciences and Kyoto University Achieve Breakthrough Preclinical Results in Boron Neutron Capture Therapy (BNCT) with Promising Implications for Cancer Treatment
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences, in collaboration with Kyoto University and Principal Investigator Dr. Fuyuhiko Tamanoi, is pleased to announce groundbreaking preclinical results in Boron Neutron Capture Therapy (BNCT). Utilizing TAE Life Science’s novel boron-10 drugs and Kyoto University Research Reactor (KURR) neutron source has generated significant pre-clinical data that may redefine the potential of BNCT in cancer treatment. Recently published in the Journal of MedicinaTAE Life Sciences and CNAO Announce Definitive Agreement on BNCT, a Next-Generation Cancer Therapy
PAVIA, Italy--(BUSINESS WIRE)--TAE Life Sciences (TLS), a leading developer of Boron Neutron Capture Therapy (BNCT) systems and drugs, and the Italian National Center for Oncological Hadrontherapy (CNAO), a premier hadrontherapy center in Europe, today announced a definitive agreement to collaborate on groundbreaking global drug research and development initiatives for the implementation of BNCT. This strategic partnership will bring together the expertise of two innovative leaders in cancer trTAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe
IRVINE, Calif.--(BUSINESS WIRE)--TAE Life Sciences (TLS), a leader in developing boron neutron capture therapy (BNCT) technology and associated innovative boron target drugs, and Stella Pharma, the pioneering developer of boronophenylalanine (BPA) under the product name Steboronine® for BNCT, are pleased to announce a strategic collaboration focused on the development, commercialization and expansion of BNCT using BPA in the United States and European markets. Stella Pharma’s BPA drug is the woTAE Life Sciences Appoints Commercial Leadership Team and Announces Distribution Deal with Radiosurgery Global
Committed to Driving the Adoption of Boron Neutron Capture Therapy for Cancer, TAE Life Sciences Bolsters Resources to Expand the Number of Alphabeam Clinical Installations Worldwide IRVINE, Calif., June 4, 2024 /PRNewswire/ -- TAE Life Sciences, a pioneer in advancing Boron Neutron...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding TAE Life Sciences
Sign Up For FreeTo access detailed company insights
TAE Life Sciences is pioneering advancements in cancer treatment through its innovative Boron Neutron Capture Therapy (BNCT) technology. The company focuses on providing effective treatment options for patients with challenging malignancies, utilizing a biologically targeted radiotherapy approach that minimizes damage to healthy tissues. Their prop... Read More
